Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Global HealthASX:GLH -19.35% Days Sales Outstanding is 35.55 as of Dec. 2025, which is 43% below its 10-year median of 61.99. The stock has 6 warning signs investors should review. Among 659 Healthcare Providers & Services companies, Global Health ranks better than 76.02% on this metric.
Global Health's average Accounts Receivable for the
six
months ended in Dec. 2025 was A$0.70 Mil. Global Health's Revenue for the
six
months ended in Dec. 2025 was A$3.59 Mil.
Hence, Global Health's Days Sales Outstanding for the
six
months ended in Dec. 2025 was 35.55.
The historical rank and industry rank for Global Health's Days Sales Outstanding or its related term are showing as below:
ASX:GLH'
s Days Sales Outstanding Range Over the Past 10 Years
Min: 25.18 Med: 61.99 Max: 182.5
Current: 25.18
During the past 13 years, Global Health's highest Days Sales Outstanding was 182.50. The lowest was 25.18. And the median was 61.99.
ASX:GLH's Days Sales Outstanding is ranked better than 76.02% of 659
companies
in the Healthcare Providers & Services industry
Industry Median: 45.82
vs ASX:GLH: 25.18
Global Health's Days Sales Outstanding
increased
from Dec. 2024 (23.96) to Dec. 2025 (35.55).
Global Health (ASX:GLH) Days Sales Outstanding Explanation
For retailers, when we compare Days Sales Outstanding, it is important to compare the same period in the previous years.
Global Health Days Sales Outstanding Related Terms
Global Health Days Sales Outstanding Historical Data
* Premium members only.
The historical data trend for Global Health's Days Sales Outstanding can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
ASX:GLH vs VEEV, BTSG, TEM: Days Sales Outstanding Comparison
For the Health Information Services subindustry, Global Health's Days Sales Outstanding, along with its competitors' market caps and Days Sales Outstanding data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Global Health Days Sales Outstanding vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Global Health's Days Sales Outstanding distribution charts can be found below:
* The bar in red indicates where Global Health's Days Sales Outstanding falls into.
Days Sales Outstanding measures the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Global Health (ASX:GLH) has a Days Sales Outstanding of 35.55 as of Dec. 2025. Days sales outstanding represents the average amount of days a company takes to collect receivables. View historical data on Global Health and its competitors. This is 43% below median its historical median of 61.99. Over the past decade, Global Health's Days Sales Outstanding has ranged from 25.18 to 182.50. According to the industry distribution chart, Global Health ranks #158 out of 659 companies in the Healthcare Providers & Services industry, placing it in the top 24%.
Is Global Health's Days Sales Outstanding too high?
Global Health's current Days Sales Outstanding of 35.55 is 43% below median its 10-year median of 61.99. Over the past 10 years, this metric has ranged from a low of 25.18 to a high of 182.50. The Healthcare Providers & Services industry median Days Sales Outstanding is 45.82. Global Health's value of 35.55 is 22.4% below this industry median. Based on the distribution chart, Global Health ranks #158 out of 659 companies in the Healthcare Providers & Services industry, which is in the top quartile — a strong position relative to peers.
How does Global Health's Days Sales Outstanding compare to VEEV and BTSG?
According to the Healthcare Providers & Services industry distribution chart, Global Health ranks #158 out of 659 companies for Days Sales Outstanding. This places Global Health in the top 24% of its industry — outperforming the majority of peers. The industry median Days Sales Outstanding is 45.82. Global Health's value of 35.55 is 22.4% below this benchmark. Historically, Global Health's own Days Sales Outstanding has ranged from 25.18 to 182.50 over the past decade. While the company's 10-year median is 61.99 vs. the industry median of 45.82, Global Health has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Sales Outstanding for a Healthcare Providers & Services company?
The median Days Sales Outstanding among Healthcare Providers & Services companies is 45.82, based on 659 companies in the industry. Companies in the top quartile (top 25%) have a Days Sales Outstanding significantly above this median, while those in the bottom quartile fall well below. However, Days Sales Outstanding should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Global Health's current Days Sales Outstanding of 35.55 is 22.4% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Sales Outstanding mean?
A high Days Sales Outstanding can signal that a stock is expensive relative to its fundamentals. Days sales outstanding represents the average amount of days a company takes to collect receivables. View historical data on Global Health and its competitors. For the Healthcare Providers & Services industry, the median Days Sales Outstanding is 45.82 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Global Health's current Days Sales Outstanding is 35.55, which is 43% below median its own 10-year median of 61.99. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Global Health stock overvalued right now?
Based on GuruFocus' analysis, Global Health (ASX:GLH) is currently considered Possible Value Trap. The stock's GF Value™ is A$0.11, compared to a current price of A$0.05 — trading 54.5% below its estimated fair value. The current Days Sales Outstanding is 35.55, which is 43% below median its 10-year median of 61.99 and 22.4% below the Healthcare Providers & Services industry median of 45.82. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Sales Outstanding calculated?
Days Sales Outstanding is calculated from a company's financial statements. For Global Health (ASX:GLH), the current Days Sales Outstanding is 35.55 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Global Health Ltd is engaged in developing, selling, and supporting application software for the healthcare sector in Australia. It operates in a single segment, being the computer technology, software, and services industry. The solutions provided by the company includes Electronic Medical Records, Client Management Systems, Patient Administration Systems, Practice Management Systems, Secure Messaging, and others.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ASX:GLH has been successfully added to your 
